TNDM LongMaking a pullback pattern near prior pivot, normally is a very bullish setup. It still has to cross that trend line to trigger the entry
−3.44USD
−222.61 MUSD
747.72 MUSD
64.13 M
About Tandem Diabetes Care, Inc.
Sector
Industry
CEO
John F. Sheridan
Website
Headquarters
San Diego
Employees (FY)
2.4 K
Founded
2006
ISIN
US8753722037
FIGI
BBG0019V9M65
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
Will TNDM reach the price level it deserves?1) I drew Resistance Line on RSI indicator and it has been broken this month clearly. Also RSI has 2 moving averages and they crossed each other. Purple(40.29) one is more than Green(35.77) one.
2) I drew Resistance and Support Lines on Momentum indicator. Resistance line has been broken. Security h
QuantProgram seems effective for longer than 5minutes chartThe script developed by QuantProgram seems effective..
TNDM in extreme consolidation faze ➕last time it was here we saw about 6 months of consolidation, so better to wait for clear trigger break, and also shares over options due to wide spread on option chains.
long trigger is 77.60 / short trigger 47.78
TNDM looks bearishAfter a significant drop in the past 5 years, the price has raised significantly, and it seems to be a good short trade.
Inverse Head and ShouldersIt is like SELL SELL SELL until no one is left to sell..so demand increases..Setting bollinger bands on a 80 MA verses a 20 MA can show extreme selling pressure when candles fall out of the bottom band. Set them on a 3 standard deviation with a 80 MA to see Extreme selling pressure..
There is a fa
Inverse Head and ShouldersEstimated Earnings 2-24 AMC..
TNDM is trying hard to push through the resistance of the neckline which is at 98.70..Once it gets through that with a bullish candle or an uptrend, then could be a good trade as these patterns are fairly reliable. The neckline would become support..
This one can be v
TAKE A LOOK AT THIS GRAPH (TNDM)Correct me if I am wrong but based off my analysis it seems that TNDM is in it for the Long.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TNDM is 31.86 USD — it has decreased by 4.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tandem Diabetes Care, Inc. stocks are traded under the ticker TNDM.
Tandem Diabetes Care, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Tandem Diabetes Care, Inc. has a max estimate of 60.00 USD and a min estimate of 18.00 USD.
TNDM earnings for the last quarter are −0.51 USD whereas the estimation was −0.48 USD which accounts for −6.40% surprise. Estimated earnings for the next quarter are −0.27 USD. See more details about Tandem Diabetes Care, Inc. earnings.
Tandem Diabetes Care, Inc. revenue for the last quarter amounts to 185.62 M USD despite the estimated figure of 192.76 M USD. In the next quarter revenue is expected to reach 203.49 M USD.
Yes, you can track Tandem Diabetes Care, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, TNDM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tandem Diabetes Care, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 2.40 K employees. See our rating of the largest employees — is Tandem Diabetes Care, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Tandem Diabetes Care, Inc. EBITDA is −138.77 M USD, and current EBITDA margin is −18.56%. See more stats in Tandem Diabetes Care, Inc. financial statements.